The first global, truly digital, full-service CRO
The first global, truly digital, full-service CRO
Exom is globally acting full-service CRO committed to the modernization of clinical trials through implementation of innovative digital solutions. By combining our expertise in managing clinical trials with our proprietary, multi-modular and cloud-based platform Genius SUITE™, Exom improves efficiencies and escalates process speeds, while ensuring high-quality data and cost reduction, from early phase to late stage & outcome studies. We are providing our services and solutions for Phase I-IV studies, NISs and Investigator Initiated Trials on drugs, nutraceuticals, and medical devices.
Exom Group is now part of Clinscience the subsidiary CRO of Neuca Group
Milano (Italy), September 2021 – Exom Group Srl, the “Full-Service Expert & Digital CRO”, with the aim of strengthening both its international operational infrastructure and the widespread use of its advanced digital solutions for clinical research, has joined Clinscience, the Neuca Group subsidiary dedicated to management of clinical trials.
Consistent with its mission that, since its foundation in 2014, has been the implementation of the next-generation clinical trial 5.0 processes, through the combination of human expertise with the efficiency of digital technologies and advanced analytics to provide study sponsors with value-added services and exceptional study experience, Exom will benefit of the Clinscience additional knowledge and experience…
Our Mission is to implement the next generation clinical trial 5.0 processes, through the combination of human expertise with the efficiency of digital technologies and advanced analytics to provide our customers with value added services and exceptional study experience.
Our international network qualified Partners (Exom Alliance), trained to Exom’s technologies and processes, provides an established organization, active across the whole of Europe, North America and other important markets. Our mission is to innovate clinical research with passion, integrity, transparency, caring and innovation.
Consulting
Study- & Protocol Design
Feasibility & Site Selection
Regulatory Services
Medical Writing
Study Management
Data-Driven and Risk-Based
Monitoring and Management
Central Event Adjudication
Data Management
Statistical Analysis
Report Writing
Medical Monitoring & PV
Lab Support Services
Quality Assurance
Auditing
Trial Supply Management
Peri & Post Approval & IITs
Our Vision is to…
Transform clinical trials conduction by connecting scientific expertise with advanced digital technologies and newly re-engineered operational processes.
Assure the achievement of high-quality standards and prevent any risk that could potentially harm study results.
Operate through data-driven management and risk-based monitoring (DDM & RBM) approach.
Reduce the overall costs while increasing quality and performance.
Therapeutic Expertise
Exom’s Clinical research professionals share the passion for quality and performance through the digital innovation of working processes. They have a solid expertise and experience (average 6-7 years) in clinical trials conduct.
- Oncology & Hematology
- Cardiovascular & Metabolic Diseases
- Central Nervous System (CNS) Disorders
- Rare Diseases
- Respiratory
- Infectious Diseases
- Urology
- Gastroenterology
- Critical Care
- Immunology
Therapeutic Expertise
Exom’s Clinical research professionals share the passion for quality and performance through the digital innovation of working processes. They have a solid expertise and experience (average 6-7 years) in clinical trials conduct.
[sg_popup id=4176]
- Oncology & Hematology
- Cardiovascular & Metabolic Diseases
- Central Nervous System (CNS) Disorders
- Rare Diseases
- Respiratory
- Infectious Diseases
- Urology
- Gastroenterology
- Critical Care
- Immunology
Geremy Project: Exom is part of a project to find a genetic cure for cardiomyopathy
Milan, Italy | Exom Group is proud to be part of the Geremy project – a project seeking a genetic cure for inherited arrhythmogenic cardiomyopathy (ACM), a rare cardiac disease – funded by the European Union as part of the Horizon 2022 program. We are joining forces...
Genius vENGAGE – Remote Verbal Consent
Genius vENGAGE: The Remote Verbal Consent for a Patient-Centric Clinical Trial Exom Group, a Clinscience company, is proud to announce the release of the first patient-centric “reliable & compliant” remote verbal consent for clinical trials (Genius vENGAGE). The...